by Raynovich Rod | Sep 25, 2015 | Biopharmaceuticals
After the close 9/25…The bio-bubble has burst. XBI down 6.85%, IBB down 4.91%. Can healthcare sector recover? —– Bull Market Intact But Sentiment Has Turned Negative The severe 20%++ correction in the biotech sector is getting a lot of bearish...
by Raynovich Rod | Sep 21, 2015 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update-1… 9/22/15 …Biotech Stocks Trade Down Another Day Biotech stocks were weak tracking NASDAQ which was down 1.5%. The IBB was down 1.49% to $335.40 flat over one month and up 10.57% YTD. The August low was $325 and the IBB is 16% off July 20 highs....
by Raynovich Rod | Sep 11, 2015 | Biopharmaceuticals
Update-1… 3P September 17 after FED Says No Rate Hike-Biotechs Rally NASDAQ up 0.8% after initial surge Apparently biotech stocks are sensitive to interest rate hikes as many analysts have suggested. Biotech companies need a continual inflow of capital and would...
by Raynovich Rod | Sep 1, 2015 | Biopharmaceuticals
Update -2… 9/8 Rally Time Today Forecasted by Friday’s Action ETF Summary -One month and YTD % FBT (12.36), +9.2% IBB (8.9), +11.3% XBI (10.12), +17.27% The five star Fidelity Select Biotech Portfolio (FBIOX) pretty much tracks the IBB up 11.66% YTD and...
by Raynovich Rod | Aug 27, 2015 | Biopharmaceuticals
Biotech ETFs Rally Back This Week 8/28 After Close The IBB closed at 353.28 up 0.68% and up 3.95% over 5 days. Next week we will provide an analysis of three ETFs -FBT,IBB and XBI- compared to one large fund the Fidelity Select Biotech Portfolio (FBIOX). All of the...
by Raynovich Rod | Aug 24, 2015 | Biopharmaceuticals
Nowhere to Hide in Another 4% Correction 8/25/15 Futures Look Promising at 11p EDT; NIKKEI 225 UP 4.8% Today’s market reached epic proportions of volatility and extremes exacerbated by a DOW opening “flash crash” off 1100 points that distorted faith...
by Raynovich Rod | Aug 21, 2015 | Biopharmaceuticals
At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218 —- Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349 Biotech Breakdown: Relief Today Or Another Head Fake? Biotech stocks are trying to hold the May lows with the IBB at $342 but...
by Raynovich Rod | Aug 13, 2015 | Biopharmaceuticals
Update-1 August 19… Dawg Days of August Biotech stocks remain weak with momentum plays hit the hardest. The IBB could test the recent bottom of 359 hit on reversal day last Friday and another low on August 7. There is strong support at this level so any...
by Raynovich Rod | Aug 10, 2015 | Biopharmaceuticals
Look For Bottom in Biotech Today after 7-10% Correction from July Highs Update-3… 8/12…Technical Bottom Hit in Biotechs-IBB Up 0.78% Near Close Update-2…8/12…XBI Hits low of $225 today and bounces back-down 10.4% over 5 days. Look for bottom in...
by Raynovich Rod | Aug 4, 2015 | Biopharmaceuticals
August 6…Rally Fails: Sell-Off Underway 11:24A EDT The sell-off in biotech began at the opening and continues two hours later. The speculative smaller cap Exchange Traded Fund XBI is down 3%. There is a red screen across the board with many high fliers down 4%....